Skip to main content
ADMA BIOLOGICS, INC. logo

ADMA BIOLOGICS, INC. — Investor Relations & Filings

Ticker · ADMA ISIN · US0008991046 US Manufacturing
Open in API
Filings indexed 962 across all filing types
Latest filing 2021-01-26 Regulatory Filings
Country US United States of America
Listing US ADMA

About ADMA BIOLOGICS, INC.

https://www.admabiologics.com/

ADMA Biologics, Inc. is an end-to-end commercial biopharmaceutical company that develops, manufactures, and commercializes specialty plasma-derived biologics. The company's portfolio features FDA-approved immune globulin (Ig) products for the treatment of immune-compromised patients and individuals at risk for certain infections. ADMA Biologics operates a vertically integrated manufacturing process for its specialty biologic products and utilizes a patented immunotechnology platform, which includes a proprietary microneutralization assay to measure neutralizing antibody levels in plasma. The company also offers contract manufacturing capabilities.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2021
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, which is a regulatory filing used to announce major events or other reportable occurrences. The text includes a press release about a CMS J-code issuance for a product, attached as an exhibit. The document length is 3274 characters, which is relatively short and primarily serves as an announcement rather than a detailed report. There are no financial statements or substantive financial data included. The document is not an annual or quarterly report, earnings release, or any other detailed financial report. It fits the definition of a Regulatory Filing (RNS) as a general regulatory announcement that does not fit into other specific categories.
2021-01-26 English
Regulatory Filings 2021
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The text specifically mentions the issuance of a press release announcing preliminary unaudited fourth quarter and full year 2020 revenues, commercial updates, and strategic outlook. The document is short (3665 characters) and primarily serves as a notification of the press release rather than containing detailed financial statements or comprehensive analysis. According to the MENU VS MEAL RULE, such a document is an announcement of a report or event rather than the report itself. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2021-01-19 English
Regulatory Filings 2021
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce significant events. The content includes an announcement about CMS approval of a new reimbursement code and references a press release attached as an exhibit. The document length is 3205 characters, which is relatively short and primarily serves as an announcement rather than a detailed report. There are no financial statements or detailed financial data present. This fits the profile of a Regulatory Filing (RNS), which is a general regulatory announcement that does not fit into more specific categories like Annual Report or Earnings Release.
2021-01-04 English
Regulatory Filings 2020
Regulatory Filings Classification · 95% confidence The document is a Form 8-A filed with the SEC, which is used for the registration of certain classes of securities pursuant to Section 12(b) or (g) of the Securities Exchange Act of 1934. The text describes the adoption of a Rights Agreement related to preferred stock purchase rights, including detailed terms and conditions of the rights, exercisability, triggers, and redemption. This is a regulatory filing related to securities registration and rights issuance, not a financial report, earnings release, or management discussion. It is not an announcement of a report publication but a formal registration statement. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length and content support a high confidence in this classification.
2020-12-16 English
Regulatory Filings 2020
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC by ADMA Biologics, Inc. The text describes the adoption of a Rights Agreement by the Board of Directors, including detailed terms of the rights issued to shareholders. Form 8-K filings are used to report major corporate events and material definitive agreements, not to present full financial statements or annual/quarterly results. The content focuses on a corporate governance action (adoption of a Rights Agreement) rather than financial results or management discussion. Therefore, this filing is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement of a material event and does not fit into more specific categories like Annual Report, Interim Report, or Capital Update. The document length and detail confirm it is not a brief announcement but a full Form 8-K report, which falls under Regulatory Filings as per the definitions provided.
2020-12-16 English
Capital/Financing Update 2020
Capital/Financing Update Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content details an amendment to a credit agreement, including new loan tranches, prepayment of a subordinated loan, extension of maturity dates, and issuance of warrants. It includes specific financial terms and contractual changes related to financing. This fits the category of Capital/Financing Update (CAP), as it provides updates on the company's financing activities and capital structure changes. The document is not an annual or quarterly report, audit report, or earnings release, nor is it a regulatory filing of miscellaneous nature. It is a substantive update on financing arrangements.
2020-12-09 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.